RecruitingNCT04528511

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction: the BENEFIT-AMI Multicenter Prospective Registry

Sponsor

Shanghai 10th People's Hospital

Enrollment

774 participants

Start Date

Oct 1, 2020

Study Type

OBSERVATIONAL

Conditions

Acute Myocardial Infarction Atrial Fibrillation New Onset

Summary

To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking what happens to patients who develop a new irregular heartbeat (called atrial fibrillation) while they are in the hospital recovering from a heart attack. **You may be eligible if...** - You are over 18 years old - You had a heart attack (either a STEMI or NSTEMI) and developed a new irregular heartbeat during that hospital stay - You received continuous heart rhythm monitoring for at least 5 days in the hospital - You are willing to give informed consent **You may NOT be eligible if...** - You had a history of atrial fibrillation before your heart attack - You have a history of rheumatic valve disease or sick sinus syndrome - You needed emergency open-heart bypass surgery - You have a cancer with a life expectancy under 1 year - You refused heart rhythm monitoring during your hospital stay Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.